Search Results

CA-224 5mg 5mg  | Purity Not Available

Adooq Bioscience

CA-224 is potent CDK4 inhibitor,is also a nonplanar analogue of fascaplysin that specifically inhibits Cdk4-cyclin D1 in vitro.

More Information Supplier Page

CA-224 25mg 25mg  | Purity Not Available

Adooq Bioscience

CA-224 is potent CDK4 inhibitor,is also a nonplanar analogue of fascaplysin that specifically inhibits Cdk4-cyclin D1 in vitro.

More Information Supplier Page

CA-224 10mg 10mg  | Purity Not Available

Adooq Bioscience

CA-224 is potent CDK4 inhibitor,is also a nonplanar analogue of fascaplysin that specifically inhibits Cdk4-cyclin D1 in vitro.

More Information Supplier Page

ASP9521 5mg 5mg  | Purity Not Available

Adooq Bioscience

ASP9521 is a novel, selective, orally bioavailable inhibitor of 17??-hydroxysteroid dehydrogenase type 5 (17bHSD5, AKR1C3).

More Information Supplier Page

ASP9521 25mg 25mg  | Purity Not Available

Adooq Bioscience

ASP9521 is a novel, selective, orally bioavailable inhibitor of 17??-hydroxysteroid dehydrogenase type 5 (17bHSD5, AKR1C3).

More Information Supplier Page

ASP9521 10mg 10mg  | Purity Not Available

Adooq Bioscience

ASP9521 is a novel, selective, orally bioavailable inhibitor of 17??-hydroxysteroid dehydrogenase type 5 (17bHSD5, AKR1C3).

More Information Supplier Page

Gilteritinib 5mg 5mg  | Purity Not Available

Adooq Bioscience

Gilteritinib is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations.

More Information Supplier Page

Gilteritinib 25mg 25mg  | Purity Not Available

Adooq Bioscience

Gilteritinib is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations.

More Information Supplier Page

Gilteritinib 10mg 10mg  | Purity Not Available

Adooq Bioscience

Gilteritinib is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations.

More Information Supplier Page

CF-102 25mg 25mg  | Purity Not Available

Adooq Bioscience

CF-102 is an orally bioavailable, synthetic, highly selective adenosine A3 receptor (A3AR) agonist with potential antineoplastic activity.

More Information Supplier Page